Australian Peptide Prices: Price Index and Comparison
The median Australian price for retatrutide is A$11.60 per mg across 3 suppliers, as of 12 October 2026.
Median, lowest and highest listed price per milligram across in-stock, single-vial listings from suppliers based in Australia that we track. Updated daily. No supplier pays to appear.
16peptides priced
62qualifying Australian listings
12 Oct 2026newest price check
The index
| Peptide | Median A$/mg | Lowest A$/mg | Highest A$/mg | Suppliers | Last updated |
|---|---|---|---|---|---|
| Retatrutide | A$11.60 | A$8.64 | A$16.00 | 3 | 12 Oct 2026 |
| Tirzepatide | A$8.45 | A$6.90 | A$10.00 | 2 | 12 Oct 2026 |
| BPC-157 | A$8.50 | A$7.01 | A$10.00 | 2 | 12 Oct 2026 |
| Semaglutide | No qualifying Australian listings right now | ||||
| TB-500 | A$10.95 | A$10.00 | A$11.90 | 2 | 12 Oct 2026 |
| AOD-9604 | A$14.01 | A$14.00 | A$18.00 | 2 | 12 Oct 2026 |
| Epithalon | A$2.86 | A$1.26 | A$8.00 | 3 | 12 Oct 2026 |
| GHK-Cu | A$1.30 | A$1.20 | A$1.80 | 3 | 12 Oct 2026 |
| Kisspeptin | A$7.50 | A$6.31 | A$8.00 | 3 | 12 Oct 2026 |
| Melanotan II | A$5.90 | A$5.60 | A$8.00 | 3 | 12 Oct 2026 |
| MOTS-c | A$6.37 | A$2.23 | A$10.00 | 3 | 12 Oct 2026 |
| NAD+ | A$0.20 | A$0.18 | A$0.28 | 2 | 12 Oct 2026 |
| PT-141 | A$6.31 | A$3.50 | A$7.00 | 3 | 12 Oct 2026 |
| Selank | A$7.50 | A$6.80 | A$13.00 | 3 | 12 Oct 2026 |
| Semax | A$8.45 | A$6.31 | A$13.00 | 3 | 12 Oct 2026 |
| Ss-31 | A$8.00 | A$7.90 | A$8.90 | 3 | 12 Oct 2026 |
| Tesamorelin | A$11.50 | A$11.21 | A$14.00 | 3 | 12 Oct 2026 |
Download CSVThe CSV uses the same inclusion and rounding rules at download time; prices may have refreshed since this page loaded.
Median price over time
Scroll the chart sideways to see every date.
The chart tracks the five headline peptides. The table and CSV cover every indexed peptide.
Methodology
- Suppliers
- Research-peptide suppliers based in Australia tracked by Peptide Scanner, excluding archived and shut-down suppliers. See the supplier directory for who we track.
- Coverage
- The five headline peptides (retatrutide, tirzepatide, BPC-157, semaglutide and TB-500) always appear. Any other tracked peptide appears once it has at least three qualifying listings. Listing count is not supplier count: several vial sizes can come from the same supplier.
- Listings
- In-stock, single-vial listings priced in AUD. Bundles, multi-vial packs, pre-filled pens, kits, capsule and spray formats, multi-peptide blends, fragment variants (except HGH Fragment 176-191 itself) and sub-1 mg vials are excluded: their price per mg is not comparable to a single vial.
- CJC-1295
- CJC-1295 with DAC and CJC-1295 without DAC (Mod GRF 1-29) are two different compounds, so they have two rows. A listing counts as no DAC when its name or its product page says so. A listing that does not say is counted as CJC-1295, the name of the DAC compound.
- Price per mg
- Listed vial price divided by the labelled milligrams, not independently measured vial content. Listed prices only: we never convert currencies. Shipping and checkout charges are not included.
- Average
- We show a listing-weighted median, not an average of supplier averages. A supplier with more qualifying listings contributes more observations. The median reduces sensitivity to extremes but can still move when a listing is wrong, particularly in small samples. It is not a measure of quality.
- Refresh
- Calculated from stored listing observations. “Last updated” is the newest check among qualifying listings, not a guarantee that every listing was checked on that date. Stock and prices may have changed since observation. The chart uses available recorded daily snapshots only; listing timestamps are not used to invent historical prices.
- If our data source fails
- This page shows the most recent recorded snapshot, clearly dated.
Citing this data
This data is free to use with attribution to PeptideScanner (peptidescanner.co).
Link to this page (the URL will not change) or cite the CSV.
Monthly editions
Once a month we freeze the index so a figure can be cited by date. See the dated reports. For research use only: this index reports market prices; it is not medical or purchasing advice.